This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs

Event Date: 03/17/2020
Location: Teleconference
Subject: Advanced Medical Technology Association Board Meeting: Contain the Spread of COVID-19
FDA Participant/Group: N/A
Non FDA Participant/Group: Several board members from Advanced Medical Technology Association

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 03/19/2020
Location: Virtual
Subject: CBD Working Group Listening Session with Epilepsy Foundation
FDA Participant/Group: PATRICK COURNOYER; SHARON MAYL; APRIL ALEXANDROW; DOUGLAS THROCKMORTON; SHERENE SEPEHRI; LOWELL SCHILLER; JOSEPH FRANKLIN; MELISSA ROBB;
Non FDA Participant/Group: Abbey Roudebush, Brandy Fureman, Jacqueline French, Laura Weidner (Epilepsy Foundation );

Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 03/18/2020
Location: Virtual
Subject: Food Safety Issues in Response to COVID-19 Outbreak
FDA Participant/Group: Several Senior FDA Officials and Staff
Non FDA Participant/Group: Several representatives from the food industry, government, and academia

Event Date: 03/19/2020
Location: Virtual
Subject: Food Safety Issues in Response to COVID-19 Outbreak
FDA Participant/Group: LEEANNE JACKSON; NINA ZIMDAHL; CAITLIN BOON;
Non FDA Participant/Group: Several executives from the food and beverage industry

Official Name: Lowell Schiller, Principal Associate Commissioner for Policy

Event Date: 03/19/2020
Location: Silver Spring, MD
Subject: Listening Session with the Epilepsy Foundation
FDA Participant/Group: DOUGLAS THROCKMORTON; AMY ABERNETHY; JOSEPH FRANKLIN; SHARON MAYL; APRIL ALEXANDROW; MELISSA ROBB; SHERENE SEPEHRI; PATRICK COURNOYER;
Non FDA Participant/Group: Abbey Roudebush, Brandy Fureman, Jacqueline French, Laura Weidner (Epilepsy Foundation );

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Acting Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Laura Caliguiri, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event